The relationship between progression-free and post-progression survival in treating four types of metastatic cancer.

Cancer letters

Volumn 262, Issue 1, 2008, Pages 48-53

  Bowater, Russell J ^a   Bridge, Luke J ^b   Lilford, Richard J ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BIOLOGICAL MODEL; BREAST TUMOR; COLORECTAL TUMOR; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METASTASIS; MORTALITY; PATHOLOGY; PROSTATE TUMOR; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

MLCS; MLOWN;

EID: 71549115053     PISSN: None     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.11.032     Document Type: Article

References (0)